Navigation Links
Breast Cancer Advance

With the recent advancements in the field of cancer and our improved understanding of genetic mechanisms behind the development for breast cancer, an effective strategy to treat the disease is not so far // .

The ADAMTS genes are recent additions to a large family known as the metalloproteinases – many of which can break down tissues and have therefore been linked with tumor metastasis, or spread, through the body. Earlier studies have shown that 11 of the 19 ADAMTS genes in humans are significantly altered as breast cancer develops. Latest research now focuses on two of the genes, ADAMTS8 and ADAMTS15, which can help to predict disease outcome in breast cancer patients Differing levels of activity of these genes means that patients can be grouped into one of four categories. These categories could be used to predict the likelihood of the breast cancer recurring. Those in the highest risk category are three times more likely to have a recurrence of breast cancer, and over five times more likely to die from the disease, than patients in the lowest risk category.

It has now been discovered that several 'ADAMTS' genes are turned off in breast cancer compared to normal breast tissue, while others are switched on. These genes could be targets for the development of 'smart' drugs tailored to treat individual patients' tumours. These new findings suggest they could become robust 'markers', predicting disease outcome in breast cancer patients and identifying those patients most at risk of recurrence of the disease. "We are beginning to understand how genes contribute to breast cancer development and I am confident this work will ultimately prove valuable for both diagnosis and treatment of the disease," said Prof Edwards, one of the senior researchers involved.

The spread of breast cancer around the body is the single most important factor in breast cancer mortality. The findings of this research will play a major role in improving the futur e of breast cancer treatment which will focus on drug regimes tailored to the individual patient.


'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... , ... January 24, 2017 , ... i2i Population Health, ... chief financial officer. , “Cary’s broad financial background is an excellent ... the strategic planning and day-to-day financial operations skills we need to take the company ...
(Date:1/24/2017)... ... January 24, 2017 , ... Twelve ... round of the 2017 Cupid's Cup Entrepreneurship Competition. Chaired by Under Armour Founder ... 2017. The entrepreneurs will showcase their businesses on February 6, 2017, at Under ...
(Date:1/24/2017)... ... , ... His message has been heard by more than 100,000 students and ... , Joel Feldman, has reached his biggest national audience yet: the three million daily ... newspapers in circulation in the country, and he hopes it will help spread his ...
(Date:1/24/2017)... ... January 24, 2017 , ... Providing solutions to critical economic ... the Frank Hawkins Kenan Institute of Private Enterprise at the University ... makers identified concrete solutions at the “What’s Next, America?” conference at the Kenan ...
(Date:1/24/2017)... ... January 24, 2017 , ... The NewKILO JRP, a ... (NMIs) and co-funded by the European Union (EU), was completed in May 2015. The ... instead being maintained and used in air, which presents some challenges to establishing traceability ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... SAN FRANCISCO , Jan. 24, 2017 /PRNewswire/ ... formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of ... In-Fusion® Cloning Primer Design Tool, powered by TeselaGen Biotechnology, ... is a unique method that seamlessly joins together linear ... free, online primer design tool facilitates easy design and ...
(Date:1/24/2017)... 2017 Sherpa Clinical Packaging ( www.sherpaclinical.com ... is pleased to announce the appointment of Kevin Rosenthal as ... Sherpa team to lead Sherpa,s Operations group and ... excellence. Kevin is not new to ... He has extensive experience working for leading pharma ...
(Date:1/24/2017)... Pa. , Jan. 24, 2017   ... 2 biopharmaceutical company developing novel therapies for the ... today announced the appointment of four world-class key ... These new appointments join QR Pharma,s previous roster ... leadership and direction to support the development of ...
Breaking Medicine Technology: